MedPath

Intubation in Morbidly Obese: a Comparison of Airtraq and ILMA

Not Applicable
Completed
Conditions
Intubation Complication
Intubation; Difficult or Failed
Registration Number
NCT02969889
Lead Sponsor
Kocaeli University
Brief Summary

bmı \> 35 morbidly obese patients requiring endotracheal intubation enrolled in this trial. Divided into two groups Airtraq and ILMA. their effectiveness is evaluated.

Detailed Description

80 patients, 18-65 years of aged ASA I-III, BMI\> 35 patients enrolled in this trial.

Divided into two groups ; Airtraq and ILMA .

BMI\>35, upper airway tumour , respiratory infection less than ten days, excluded from this study.

patients demographic and airway variables were recoded. Patients were premedicated. After standard anesthesia induction, anesthesia was induced with propofol and fentanyl. Rocuronium was used for neuromuscular blockade.

The device insertion and intubation times, number of intubation attempts, mucosal damage, need for optimization maneuvers, effects on hemodynamic parameters and postoperative minor complications were recorded.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria

18-65 years of age

  • ASA I-III
  • BMI>35
Exclusion Criteria

BMI<35

  • patients have airway tumor
  • patients undergoing head and neck surgery
  • upper respiratory infection less than 10 days prior the surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
intubation time1 minute

handling of the device till the endotracheal tube entering the glottis

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Kocaeli University School of Medicine

🇹🇷

Kocaeli, Turkey

Kocaeli University School of Medicine
🇹🇷Kocaeli, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.